SEC Form 4 · accession 0001000229-17-000035
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Bergmark
Officer — EVP & CFO · Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Performance SharesF1 | $0.00 | Feb 14, 2017 | A | 15,804 | A | — | — | Common Shares | 15,804 | 15,804 | D |
Explanation of responses
- F1Assuming a recipient's continued employment (or death/disability while employed) and the satisfaction of certain performance goals is achieved, these awards would vest at the end of a 3-year performance period that began on 1/1/17 and ends on 12/31/19 (the "Performance Period"). At the end of the Performance Period, 50% of the award will vest if the Company is in the top 50th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 75th percentile of ROIC of the BPG and 150% of the award will vest if the Company is the top performing company of the BPG, all as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. The award will be extrapolated on a straight line basis between the 50th and 100th percentile. If the minimum criterion is not met, then no shares shall vest and the award shall be forfeited.